Cargando…
Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury
AIM: To investigate the efficacy and safety of a dipeptidyl peptidase-4 inhibitor, sitagliptin, for treating diabetes mellitus complicated by chronic liver injury. METHODS: Sitagliptin was administered for 13.7 ± 10.1 months to 122 patients with DM complicated by chronic liver injury (including 19 p...
Autores principales: | Asakawa, Masahiro, Mitsui, Hiroshi, Akihisa, Momoko, Sekine, Tetsuo, Niitsu, Yoshihiro, Kobayashi, Arisa, Miyake, Atsuko, Hashimoto, Naoaki, Kawamura, Mitsunobu, Ogawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501339/ https://www.ncbi.nlm.nih.gov/pubmed/26191473 http://dx.doi.org/10.1186/s40064-015-1135-z |
Ejemplares similares
-
A Case of Rathke's Cleft Cyst Associated with Transient Central Adrenal Insufficiency and Masked Diabetes Insipidus
por: Asakawa, Masahiro, et al.
Publicado: (2014) -
Novel splice site mutation in GATA3 in a
patient with HDR syndrome
por: Matsuo, Kumihiro, et al.
Publicado: (2017) -
Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
por: Kubota, Akira, et al.
Publicado: (2012) -
Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
por: Fukuda, Masahiro, et al.
Publicado: (2018) -
Postprandial and Orthostatic Hypotension Treated by Sitagliptin in a Patient with Dementia with Lewy Bodies
por: Saito, Yoshihiro, et al.
Publicado: (2016)